Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 0.00 |
Average volume | -- |
---|---|
Shares outstanding | 267.52m |
Free float | 95.37m |
P/E (TTM) | -- |
Market cap | 317.28m SEK |
EPS (TTM) | -0.0209 SEK |
Data delayed at least 15 minutes, as of Apr 24 2024.
More ▼
Announcements
- Karolinska Development divests its holding in the Danish dermatology company Henlez
- Karolinska Development avyttrar hela innehavet i det danska dermatologibolaget Henlez
- Karolinska Developments portföljbolag AnaCardio rapporterar framsteg i två kliniska studier av läkemedelskandidaten AC01
- Karolinska Development’s portfolio company AnaCardio reports progress in two clinical trials with its drug candidate AC01
- Karolinska Developments portföljbolag BOOST Pharma presenterar positiva top line-resultat från en fas 1/2-studie med över 75% minskning av frakturfrekvensen hos barn med sällsynt bensjukdom
- Karolinska Developments portfolio company BOOST Pharma announces positive top-line results from a Phase 1/2 study with over 75% reduction of fracture rates in children with rare bone disease
- Karolinska Development’s portfolio company Biosergen announces successful treatment of first patient in a clinical trial of BSG005
- Karolinska Developments portföljbolag Biosergen meddelar framgångsrik behandling av första patienten i klinisk studie med BSG005
- Interim Report - January-June 2024
- Delårsrapport för januari – juni 2024
More ▼